The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Solove Research Institute
Welcome,         Profile    Billing    Logout  
 0 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tinoco, Gabriel R
MOTION, NCT05059262 / 2020-004883-25: Study of Vimseltinib for Tenosynovial Giant Cell Tumor

Active, not recruiting
3
120
Europe, Canada, US, RoW
vimseltinib, DCC-3014, Placebo
Deciphera Pharmaceuticals LLC, Deciphera Pharmaceuticals, LLC
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Diffuse, Tenosynovial Giant Cell Tumor, Localized
08/23
07/26
MANEUVER, NCT05804045: Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor

Active, not recruiting
3
90
Europe, Canada, US, RoW
Pimicotinib(ABSK021), Placebo
Abbisko Therapeutics Co, Ltd
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath
05/26
06/28
NCT05580588: Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

Terminated
2
14
US
SPH4336
Shanghai Pharma Biotherapeutics USA Inc.
Liposarcoma, Dedifferentiated
10/24
10/24
NCT06528769: Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients with Advanced Leiomyosarcoma

Not yet recruiting
2
16
US
all-trans retinoic acid, ATRA, retinoic acid, tretinoin, vitamin A acid, Cemiplimab, libtayo, Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal REGN2810 Heavy Chain), Disulfide with Human Monoclonal REGN2810 kappa-chain, REGN-2810, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Magnetic resonance imaging, MRI, MRI scan, Magnetic Resonance, Medical Imaging, Nuclear Magnetic Resonance, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection
Gabriel Tinoco
Leiomyosarcoma, Sarcoma
12/27
12/27
NCT04278781: AG-120 in People With IDH1 Mutant Chondrosarcoma

Active, not recruiting
2
6
US
AG-120
Memorial Sloan Kettering Cancer Center, Agios Pharmaceuticals, Inc.
Chondrosarcoma, Chondrosarcoma, Grade 2, Chondrosarcoma, Grade 3, IDH1 Gene Mutation
03/26
03/26
BA3011-001, NCT03425279: CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients with Sarcoma

Active, not recruiting
1/2
300
US, RoW
CAB-AXL-ADC, PD-1 inhibitor
BioAtla, Inc.
Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma
01/25
01/25
NCT03994627: Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma

Approved for marketing
N/A
Europe, Canada, US, RoW
Olaratumab, LY3012207
Eli Lilly and Company
Soft Tissue Sarcoma
 
 
NCT05653388: Metastatic Leiomyosarcoma Biomarker Protocol

Recruiting
N/A
200
US, RoW
Plasma Collection
University of Michigan Rogel Cancer Center, National Cancer Institute (NCI)
Leiomyosarcoma
12/26
12/26

Download Options